Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab + Trastuzumab + Capecitabine in HER2+ Metastatic Breast Cancer
NCT00811135Phase 2Completed
- Sponsor
- Roche
- Start
- Dec 2008
- Primary completion
- Dec 2015
- Modality
- Monoclonal Antibodies
- Countries
- 6
01
Overview
A Phase 2 trial of bevacizumab in breast cancer, sponsored by Roche. Started Dec 2008; status: completed.
02
Drugs
bevacizumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00811135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00811135.